Repligen (RGEN) Non Operating Income (2012 - 2026)
Repligen (RGEN) posted quarterly Non Operating Income of $177000.0 for Q2 2026, down 95.9% year-over-year from $4.3 million in Q2 2025, and up 101.25% quarter-over-quarter from -$14.2 million in Q1 2026.
Repligen (RGEN) Non Operating Income (2012 - 2026) Analysis & Trends
Repligen (RGEN) has reported Non Operating Income for 12 consecutive years, with $177000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Non Operating Income fell 95.9% year-over-year to $177000.0; the TTM figure through Jun 2026 stood at -$12.5 million (down 221.43% YoY), while the FY2025 annual figure was $7.2 million, down 10.68% from the prior year.
- Non Operating Income advanced to $177000.0 in Q2 2026 per RGEN's latest filing, from -$14.2 million in the prior quarter.
- Across five years, Non Operating Income topped out at $6.7 million in Q3 2023 and bottomed at -$14.2 million in Q1 2026.
- Historically, Non Operating Income has averaged $265444.4 across 5 years, with a median of $766000.0 in 2025.
- Annual changes were most pronounced in 2025 — Non Operating Income soared 2581.82% — and 2026, when it sank 1137.95%.
- Repligen's Non Operating Income stood at $4.1 million in 2022, then sank by 293.01% to -$8.0 million in 2023, then surged by 73.69% to -$2.1 million in 2024, then jumped by 159.09% to $1.2 million in 2025, then tumbled by 85.78% to $177000.0 in 2026.
- Business Quant data shows RGEN's Non Operating Income at $177000.0 in Q2 2026, -$14.2 million in Q1 2026, and $1.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 82.70 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 25.45 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -160.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -12.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 3.50 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn | 177,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 177,000.00 |
| Mar 31, 2026 | -14.17 Mn |
| Dec 31, 2025 | 1.25 Mn |
| Sep 30, 2025 | 287,000.00 |
| Jun 30, 2025 | 4.32 Mn |
| Mar 31, 2025 | 1.37 Mn |
| Dec 31, 2024 | -2.11 Mn |
| Sep 30, 2024 | 6.68 Mn |
| Jun 30, 2024 | 3.56 Mn |
| Mar 31, 2024 | -55,000.00 |
| Dec 31, 2023 | -8.01 Mn |
| Sep 30, 2023 | 6.69 Mn |
| Jun 30, 2023 | 5.62 Mn |
| Mar 31, 2023 | 4.70 Mn |
| Dec 31, 2022 | 4.15 Mn |
| Sep 30, 2022 | -5.20 Mn |
| Jun 30, 2022 | -3.41 Mn |
| Mar 31, 2022 | -1.07 Mn |
| Dec 31, 2021 | -2.58 Mn |
| Sep 30, 2021 | -3.96 Mn |